3-(1 H -Benzoimidazol-2-yl)-3-hydroxy-propionic acid, 95.0%, 2.5g

Thiazolo[5,4-b]pyridine, 95+%, 10g

acide méta-phosphorique, pa, morceaux (conditionné en verre), 500 g, emballage plastique.

4-Bromo-2,6-diethylbenzonitrile, 95.0%, 5g

Methyl 3-(methylsulfonamido)benzoate, 95%, 1g

(R)-2-(2-Phenylacetamido)hexanedioic acid, 100mg

N-(2-Chloroacetyl)-2-methylbenzamide, 95%, 100mg

Methyl 3-chloro-5-fluorobenzoate, 95.0%, 25g

(3R,4S)-4-(4-(Benzyloxy)phenyl)-1-(4-fluorophenyl)-3-(3-(4-fluorophenyl)-3-oxopropyl)azetidin-2-one, 98%, 5g

2-Bromo-4-chloro-5-methylpyridine, 95.0%, 2.5g

1-Benzylpiperidin-3-ol hydrochloride, 95.0%, 25g

tert-Butyl 2-(aminomethyl)piperazine-1-carboxylate, 98%, 100mg

2-Bromo-5-chloronicotinaldehyde, 95.0%, 25g